The in vitro effect of corticosteroids on components of airway remodeling Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010
Low-dose theophylline improves lung inflammatory profile during COPD exacerbations by increasing histone deacetylase activity Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008
Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation Source: Eur Respir J, 54 (3) 1901088; 10.1183/13993003.01088-2019 Year: 2019
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2 -agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
Changes in airway inflammation, remodelling and PD20 following inhaled corticosteroid treatment are not temporally concordant Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001
Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006
Restored HDAC-2 expression after corticosteroid and theophylline therapy in ex-smoker COPD patients Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008
Formoterol enhances glucocorticoid receptor nuclear translocation in steroid-insensitive severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 250s Year: 2004
Involvement of epigenetic factor in regulation of steroid resistant bronchial asthma patients Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
Formoterol restores corticosteroid responses in corticosteroid-insensitive severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 50s Year: 2005
Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016
Effects of tiotropium on neurohumoral activation during exercise in stable COPD patients Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009
Disturbances of STAT6 signaling in steroid-free asthma Source: Eur Respir J 2006; 28: Suppl. 50, 502s Year: 2006
Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010
Effects of corticosteroid or montelukast associated to iNOS inhibitior on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2011 - Translational models of disease Year: 2011
Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002
Topical evaluation of growth factors in arterial remodeling in patients with COPD and osteoporosis Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020
Effect of fluticasone and formoterol combination therapy on airway remodeling Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011